Barry D Hock1, Judith L McKenzie2, Nicholas B Cross3, Margaret J Currie4. 1. Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand; Pathology Department, University of Otago, Christchurch, New Zealand. Electronic address: barry.hock@otago.ac.nz. 2. Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand; Pathology Department, University of Otago, Christchurch, New Zealand. 3. Department of Nephrology, Christchurch Hospital, Christchurch, New Zealand. 4. Mackenzie Cancer Research Group, University of Otago, Christchurch, New Zealand.
Abstract
BACKGROUND: Myeloid-derived suppressor cells (MDSC) are powerful suppressors of immune responses. MDSC numbers are increased in some renal transplant recipients (RTR) and there is increasing interest in their potential role in promoting both transplant tolerance and transplant associated malignancy. However the factors influencing MDSC mobilisation are unknown, and the relative temporal changes in the granulocytic (G-MDSC) and monocytic (Mo-MDSC) subsets of MDSC have not been defined. METHODS: The circulating frequencies of MDSC and dendritic cells (DC) were analysed by multicolour flow cytometry in RTR (n = 8) prior to transplant and at regular intervals out to 1 year post-transplant. RESULTS: In RTRs, numbers of both G-MDSC and Mo-MDSC increased rapidly following transplant and peaked within 8 days, whilst DC numbers decreased. A second peak in G-MDSC numbers was observed in 7/8 patients within 3 months and 2 patients had a further 3rd peak in G-MDSC numbers which, in one patient, corresponded to a rejection event. Mo-MDSC numbers underwent less fluctuation and a subsequent peak in numbers was observed in only 2/8 patients. Respective kidney donors (n = 5) underwent only small transient increases in MDSC following surgery. Overall, there was little correlation between increases in MDSC and the occurrence of detectable clinical events or treatment changes. CONCLUSIONS: In RTRs, MDSC numbers increase rapidly and peak following commencement of immunosuppression, but then fluctuate in response to as yet undefined stimuli. Further studies are required to identify the factors modulating MDSC mobilisation.
BACKGROUND: Myeloid-derived suppressor cells (MDSC) are powerful suppressors of immune responses. MDSC numbers are increased in some renal transplant recipients (RTR) and there is increasing interest in their potential role in promoting both transplant tolerance and transplant associated malignancy. However the factors influencing MDSC mobilisation are unknown, and the relative temporal changes in the granulocytic (G-MDSC) and monocytic (Mo-MDSC) subsets of MDSC have not been defined. METHODS: The circulating frequencies of MDSC and dendritic cells (DC) were analysed by multicolour flow cytometry in RTR (n = 8) prior to transplant and at regular intervals out to 1 year post-transplant. RESULTS: In RTRs, numbers of both G-MDSC and Mo-MDSC increased rapidly following transplant and peaked within 8 days, whilst DC numbers decreased. A second peak in G-MDSC numbers was observed in 7/8 patients within 3 months and 2 patients had a further 3rd peak in G-MDSC numbers which, in one patient, corresponded to a rejection event. Mo-MDSC numbers underwent less fluctuation and a subsequent peak in numbers was observed in only 2/8 patients. Respective kidney donors (n = 5) underwent only small transient increases in MDSC following surgery. Overall, there was little correlation between increases in MDSC and the occurrence of detectable clinical events or treatment changes. CONCLUSIONS: In RTRs, MDSC numbers increase rapidly and peak following commencement of immunosuppression, but then fluctuate in response to as yet undefined stimuli. Further studies are required to identify the factors modulating MDSC mobilisation.
Authors: Kent P Jensen; David A Hongo; XuHuai Ji; PingPing Zheng; Rahul Pawar; Thomas Hsin-Hsu Wu; Stephan Busque; John D Scandling; Judith A Shizuru; Robert Lowsky; Asha Shori; Suparna Dutt; Jeffrey Waters; Anirudh Saraswathula; Jeanette Baker; John S Tamaresis; Philip Lavori; Robert Negrin; Holden Maecker; Edgar G Engleman; Everett Meyer; Samuel Strober Journal: Blood Adv Date: 2021-09-14
Authors: Andreas Schroeter; Maximilian J Roesel; Tomohisa Matsunaga; Yao Xiao; Hao Zhou; Stefan G Tullius Journal: Front Immunol Date: 2022-07-06 Impact factor: 8.786
Authors: María Iglesias-Escudero; David Sansegundo-Arribas; Paloma Riquelme; David Merino-Fernández; Sandra Guiral-Foz; Carmen Pérez; Rosalia Valero; Juan Carlos Ruiz; Emilio Rodrigo; Patricia Lamadrid-Perojo; James A Hutchinson; Jordi Ochando; Marcos López-Hoyos Journal: Front Immunol Date: 2020-04-30 Impact factor: 7.561
Authors: María Iglesias-Escudero; David San Segundo; David Merino-Fernandez; Victor M Mora-Cuesta; Patricia Lamadrid; Marta Alonso-Peña; Sandra Raso; David Iturbe; Sonia Fernandez-Rozas; Jose Cifrian; Marcos López-Hoyos Journal: Front Immunol Date: 2022-01-10 Impact factor: 7.561